AHG — Akso Health Cashflow Statement
0.000.00%
Last trade - 00:00- $15.55m
- $16.48m
- $13.18m
Annual cashflow statement for Akso Health, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2019 March 31st | C2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 5.53 | -47.4 | -31.6 | -16.8 | -13.1 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 7.67 | 18.6 | 18.4 | 10.8 | 11 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -11.6 | -32.9 | 23.2 | -2.56 | -1.17 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -1.73 | -58.3 | 10.1 | -8.63 | -3.25 |
| Capital Expenditures | -0.945 | -0.2 | 0 | -0.005 | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -67.2 | 13 | -0.001 | -20 | 18.5 |
| Sale of Fixed Assets | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -68.1 | 12.8 | -0.001 | -20 | 18.5 |
| Financing Cash Flow Items | -0.318 | 7.36 | 0.037 | 10 | 0 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -0.029 | -1.55 | -9.04 | 34.8 | -27.5 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -75.3 | -46.4 | 4.2 | 6.8 | -12.7 |